Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer†

(2013) T. H. van Dijk et al.   ANNALS OF ONCOLOGY

Predicting Postoperative Morbidity Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CS+HIPEC) with Preoperative FACT-C (Functional Assessment of Cancer Therapy) and Patient-Rated Performance Status

(2013) Chukwuemeka U. Ihemelandu et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

(2013) Anke M. J. Kuijpers et al.   ANNALS OF SURGICAL ONCOLOGY

Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2013) Aras Emre Canda et al.   ANNALS OF SURGICAL ONCOLOGY

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

(2013) Gabriel Glockzin et al.   BMC CANCER

Peritoneal metastases from colorectal cancer: Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

(2013) S. Riss et al.   EJSO

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

(2013) N. Bakrin et al.   EJSO

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients

(2013) G. Passot et al.   EJSO

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: A case-control study from a Chinese center

(2013) Chao-Qun Huang et al.   JOURNAL OF SURGICAL ONCOLOGY

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

Prognostic Factors for Disease-Free Survival after Preoperative Chemotherapy Followed by Curative Resection in Patients with Colorectal Cancer Harboring Hepatic Metastasis: A Single-Institute, Retrospective Analysis in Asia

(2013) Jun Ho Yi et al.   ONCOLOGY

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

(2012) Patricia Guyot et al.   BMC Medical Research Methodology

Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics

(2012) Björn L.D.M. Brücher et al.   CANCER INVESTIGATION

Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

(2012) Paul H Sugarbaker et al.   LANCET ONCOLOGY

The Role of Lung Metastasis Resection in Improving Outcome of Colorectal Cancer Patients: Results From a Large Retrospective Study

(2012) Marco Tampellini et al.   ONCOLOGIST

A new standard of care for the management of peritoneal surface malignancy

(2011) F. Mohamed et al.   Current Oncology

Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program

(2010) Terence C. Chua et al.   ANNALS OF SURGERY

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

(2010) Jan Franko et al.   CANCER

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

(2010) Olivier Glehen et al.   CANCER

Management of Peritoneal Carcinomatosis From Colorectal Cancer

(2010) Eddy Cotte et al.   CANCER JOURNAL

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: A Panacea or Just an Obstacle Course for the Patient?

(2009) Vijay P. Khatri   JOURNAL OF CLINICAL ONCOLOGY

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY